After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Solid Biosciences Inc is $425.86M. A total of 1.28 million shares were traded on the day, compared to an average of 2.09M shares.
In the most recent transaction, Bain Capital Life Sciences Inv bought 1,000,000 shares of SLDB for 4.03 per share on Feb 19 ’25. After the transaction, the 10% Owner now owns 5,034,582 company shares. In a previous transaction on Feb 19 ’25, PERCEPTIVE ADVISORS LLC bought 5,000,000 shares at 4.03 per share. SLDB shares that Director owns now total 11,833,539.
Among the insiders who bought shares, Adage Capital Management, L.P. acquired of 252,545 shares on Feb 18 ’25 at a per-share price of $7.56. This resulted in the 10% Owner holding 4,248,084 shares of SLDB after the transaction. In another insider transaction, Hanrahan Jessie sold 3,079 shares at $3.96 per share on Feb 14 ’25. Company shares held by the Chief Regulatory Officer now total 19,281.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SLDB has a high of $15.05 and a low of $2.88.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $4.29, while its Total Shareholder’s Equity was $208.21M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 5.00.
